U.S. Capital Wealth Advisors LLC Invests $2.47 Million in Globe Life Inc. $GL

U.S. Capital Wealth Advisors LLC purchased a new position in shares of Globe Life Inc. (NYSE:GL) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 19,886 shares of the company’s stock, valued at approximately $2,472,000.

A number of other institutional investors and hedge funds also recently bought and sold shares of GL. Pinnacle Wealth Planning Services Inc. increased its stake in shares of Globe Life by 4.0% in the fourth quarter. Pinnacle Wealth Planning Services Inc. now owns 2,293 shares of the company’s stock valued at $256,000 after buying an additional 88 shares in the last quarter. Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in Globe Life during the 4th quarter worth about $8,384,000. Campbell Deegan Wealth Management LLC acquired a new stake in Globe Life in the 4th quarter valued at about $246,000. Wealth Enhancement Advisory Services LLC raised its stake in shares of Globe Life by 5.9% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 20,938 shares of the company’s stock worth $2,335,000 after acquiring an additional 1,159 shares during the last quarter. Finally, 111 Capital acquired a new position in shares of Globe Life during the fourth quarter worth approximately $242,000. Institutional investors and hedge funds own 81.61% of the company’s stock.

Globe Life Trading Up 0.8%

NYSE:GL opened at $146.42 on Wednesday. The company has a current ratio of 0.06, a quick ratio of 0.06 and a debt-to-equity ratio of 0.43. Globe Life Inc. has a 1-year low of $100.27 and a 1-year high of $147.83. The firm has a market capitalization of $11.86 billion, a price-to-earnings ratio of 11.70 and a beta of 0.56. The business’s 50-day moving average price is $137.84 and its two-hundred day moving average price is $127.61.

Globe Life (NYSE:GL) last announced its quarterly earnings results on Wednesday, July 23rd. The company reported $3.27 earnings per share for the quarter, beating analysts’ consensus estimates of $3.25 by $0.02. The business had revenue of $1.48 billion for the quarter, compared to the consensus estimate of $1.50 billion. Globe Life had a net margin of 18.11% and a return on equity of 21.24%. Globe Life’s revenue for the quarter was up 2.9% on a year-over-year basis. During the same period last year, the company posted $2.97 EPS. Globe Life has set its FY 2025 guidance at 14.250-14.650 EPS. On average, equities analysts expect that Globe Life Inc. will post 13.87 earnings per share for the current year.

Globe Life Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, October 3rd will be given a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Friday, October 3rd. Globe Life’s dividend payout ratio is currently 8.63%.

Analysts Set New Price Targets

GL has been the subject of a number of research reports. Morgan Stanley raised their price target on shares of Globe Life from $166.00 to $171.00 and gave the company an “overweight” rating in a report on Monday, August 18th. Truist Financial began coverage on Globe Life in a research note on Tuesday, July 15th. They issued a “buy” rating and a $150.00 target price for the company. Cfra Research upgraded Globe Life to a “moderate buy” rating in a research report on Friday, July 25th. Keefe, Bruyette & Woods raised their price target on Globe Life from $145.00 to $155.00 and gave the company an “outperform” rating in a report on Monday, July 28th. Finally, Wells Fargo & Company lifted their price objective on Globe Life from $144.00 to $150.00 and gave the stock an “overweight” rating in a research report on Friday, July 25th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $152.45.

Insider Transactions at Globe Life

In other Globe Life news, CEO James Matthew Darden sold 33,270 shares of the firm’s stock in a transaction that occurred on Friday, July 25th. The stock was sold at an average price of $135.59, for a total value of $4,511,079.30. Following the completion of the transaction, the chief executive officer directly owned 49,842 shares in the company, valued at $6,758,076.78. This trade represents a 40.03% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Thomas Peter Kalmbach sold 28,952 shares of the business’s stock in a transaction on Tuesday, July 29th. The stock was sold at an average price of $140.97, for a total transaction of $4,081,363.44. Following the transaction, the chief financial officer owned 30,665 shares in the company, valued at approximately $4,322,845.05. The trade was a 48.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 84,722 shares of company stock valued at $11,733,793 in the last ninety days. Corporate insiders own 1.97% of the company’s stock.

About Globe Life

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.